Toth Financial Advisory’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,000	Closed	-$309K	–	970
2025 Q3	$309K	Buy	+12,000	New	+$295K	0.03%	196
2024 Q3	–	Sell	-1,332	Closed	-$38.1K	–	762
2024 Q2	$38.1K	Hold	1,332	–	–	﹤0.01%	319
2024 Q1	$38.9K	Sell	1,332 -10	-0.7%	-$307	﹤0.01%	315
2023 Q4	$45.3K	Sell	1,342 -355	-21%	-$10.4K	0.01%	306
2023 Q3	$52.1K	Hold	1,697	–	–	0.01%	265
2023 Q2	$68K	Hold	1,697	–	–	0.01%	244
2023 Q1	$69.3K	Hold	1,697	–	–	0.01%	250
2022 Q4	$65.5K	Sell	1,697 -125	-7%	-$6.08K	0.01%	257
2022 Q3	$97K	Hold	1,822	–	–	0.02%	216
2022 Q2	$106K	Sell	1,822 -11,550	-86%	-$757K	0.02%	213
2022 Q1	$1.02M	Buy	13,372 +12,239	+1,080%	+$816K	0.15%	115
2021 Q4	$68K	Hold	1,133	–	–	0.01%	272
2021 Q3	$63K	Hold	1,133	–	–	0.01%	283
2021 Q2	$69K	Sell	1,133 -17,715	-94%	-$1.12M	0.01%	253
2021 Q1	$1.32M	Buy	18,848 +1,228	+7%	+$87.7K	0.21%	92
2020 Q4	$1.05M	Buy	17,620 +2,855	+19%	+$167K	0.18%	99
2020 Q3	$888K	Buy	14,765 +25	+0.2%	+$1.45K	0.17%	102
2020 Q2	$773K	Buy	14,740 +12,890	+697%	+$539K	0.17%	100
2020 Q1	$62K	Buy	+1,850	New	+$76.9K	0.02%	168